Pizotifen

Breastfeeding
  • TRADE NAMES: Sandomigran; Sanmigran; Sanomigran (Novartis)
  • INDICATIONS: Recurrent vascular headaches, including classical migraine, common migraine and cluster headaches
  • CLASS: 5-Hydroxytryptamine antagonist
  • HALF-LIFE: 23 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Adrenergic neurone blockers , Alcohol, Antihistamines, Butalbital, Hypnotics, Isocarboxazid, Pentobarbital, Phenelzine, Phenobarbital, Primidone, Sedatives, Tranylcypromine, Zolpidem

Our database has 21 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
ENDOCRINE/METABOLIC


Page last updated 02/01/2016

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric